ev3 Neurovascular – Matthew Jenusaitis, President, will present ev3's Onyx material to treat arterio-venous malformations in the brain.  These potentially fatal anomalies are safely and reliably treated with this novel liquid polymer material that is injected into the cerebral vascular system and polymerizes to isolate the affected area.  In just 18 month, the company received FDA approval, and over 10,000 applications have been used in the U.S., and over 30,000 worldwide, converting 50% of the market.

Acclarent, Inc. – Josh Makower, MD, Founder and Chairman, will present how - in 18 months -  the company's Balloon Sinuplasty^TM devices evolved from an idea to an FDA-approved, commercial success, completely revolutionizing the treatment of chronic sinusitis along the way.  Using these devices, which have become the backbone of the Relieva® product portfolio, ENT patients now have a minimally invasive alternative to conventional endoscopic surgical approaches, resulting in much less pain and bleeding.

U.S. Medical Instruments, Inc. – Matthew Mazur, CEO, will present SafeSnap, the only safety syringe on the market that becomes its own sharps container. SafeSnap's innovative design helps prevent needle-stick injuries for healthcare workers. Close to one million healthcare workers sustain needle-stick injuries each year, exposing them to blood-borne pathogens. SafeSnap also lowers costs associated with disposal of sharps containers and reduces the tremendous amount of waste going into landfills.